Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?

To: Tech Master who wrote (14545)	6/24/1998 4:56:00 PM
From: Jeffrey S. Mitchell	Read Replies (2) \| Respond to of 17305

RIBI would be an emotional play. If approved by Canada it would give them the first commercially approved cancer vaccine. Schering has now acquired worldwide rights so I presume they have much more clout than Biomera to get the Canadian government to approve it... soon. At 5.25 it might be a decent play. Of course if there are more delays (it was supposed to be approved in April) or Melacine gets turned down, the stock will tank. So, RIBI is either a home run or a strike out. - Jeff